India, Oct. 30 -- Drug makers are under pressure to launch faster, spend smarter and stay compliant at every step. That is pushing them to hand more commercial, medical, safety and regulatory work to specialist partners. The twist today is AI. Partners that pair deep life sciences knowledge with technology are winning bigger and longer mandates, while pure headcount players find it harder to stand out.

The Nifty 50 was trading at 22,946.35, up 0.04%. Meanwhile, Sensex also rose 0.08% to 74,207.04 on Friday. Meanwhile, Shares of Indegene Ltd. were trading at Rs. 588.90, down 0.77 percent from the previous close of Rs. 593.45. The stock opened at Rs. 594.00 and reached an intraday high of Rs. 594.00 and low of Rs. 576.95. The company curr...